GT Medical Technologies, Inc.

GT Medical Technologies, Inc. is a medical device company focused on improving the lives of patients with brain tumors through its innovative GammaTile Therapy. GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) that provides immediate, dose-intense treatment at the completion of tumor resection. This groundbreaking therapy offers numerous advantages, including the ability to delay tumor recurrence, potentially extend survival, limit radiation exposure to healthy tissue, minimize side effects, and ensure treatment compliance. The company is committed to advancing safety and efficacy with continuous research and development.

GT Medical Technologies is driven by a team of dedicated professionals with extensive experience in the medical device industry and a deep passion for improving patient outcomes. The company has assembled a leadership team with expertise in areas such as clinical development, commercialization, finance, and operations. GT Medical Technologies collaborates with leading healthcare providers across the United States to ensure widespread access to its innovative brain tumor treatment. The company actively participates in clinical trials and strives to remain at the forefront of medical advancements in neuro-oncology.

GT Medical Technologies is dedicated to improving the lives of patients with brain tumors by developing and delivering innovative, safe, and effective treatment options. They strive to elevate outcomes and advance safety with their surgically targeted radiation therapy (STaRT) technology, known as GammaTile Therapy, which aims to minimize side effects and maximize local tumor control. Their mission is driven by a commitment to patients, constructive engagement, collaboration, and continuous improvement.

GT Medical Technologies promotes a culture focused on collaboration, innovation, and patient-centricity. They value constructive engagement, where all voices are heard and respected, while fostering a sense of shared purpose in improving the lives of brain tumor patients. They prioritize patient and customer focus, ensuring their needs are met at every stage. Their commitment to consistency and compliance ensures predictable positive outcomes and trust in their operations.

GT Medical Technologies, Inc. emphasizes a culture of constructive engagement and collaboration, which includes respecting and valuing diverse perspectives. Their commitment to improving the lives of patients with brain tumors extends to fostering an inclusive work environment where everyone feels supported and valued, regardless of background or identity.